BRCA mutation carriers with low baseline OPG concentrations (≤ 95 pg/ml) had a significantly higher risk of developing breast cancer compared to those with high baseline OPG concentrations (> 95 pg/ml)(Figure 1). The gene discussed is TNFRSF11B; the disease is breast carcinoma.